AdaptHealth (NASDAQ:AHCO) & Cancer Treatment (NASDAQ:CTHZ) Head-To-Head Contrast

AdaptHealth (NASDAQ:AHCO) and Cancer Treatment (OTCMKTS:CTHZ) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings.

Analyst Ratings

This is a summary of recent ratings and target prices for AdaptHealth and Cancer Treatment, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdaptHealth 0 0 6 0 3.00
Cancer Treatment 0 0 0 0 N/A

AdaptHealth presently has a consensus price target of $24.33, suggesting a potential downside of 13.53%. Given AdaptHealth’s higher possible upside, research analysts plainly believe AdaptHealth is more favorable than Cancer Treatment.


This table compares AdaptHealth and Cancer Treatment’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AdaptHealth N/A -42.67% 1.17%
Cancer Treatment N/A N/A N/A

Insider and Institutional Ownership

12.4% of AdaptHealth shares are held by institutional investors. 10.9% of AdaptHealth shares are held by company insiders. Comparatively, 56.1% of Cancer Treatment shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

AdaptHealth has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Cancer Treatment has a beta of -4.13, indicating that its stock price is 513% less volatile than the S&P 500.

Valuation & Earnings

This table compares AdaptHealth and Cancer Treatment’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AdaptHealth $529.64 million 4.48 -$15.00 million $0.30 93.80
Cancer Treatment N/A N/A N/A N/A N/A

Cancer Treatment has lower revenue, but higher earnings than AdaptHealth.


AdaptHealth beats Cancer Treatment on 6 of the 8 factors compared between the two stocks.

AdaptHealth Company Profile

AdaptHealth, LLC distributes home medical equipment. The Company offers mobility products, respiratory therapy, non- invasive ventilation, nutrition supplies, ocean home health products, sleep therapy supplies, bed lifts, seat lift chairs, and bath aids. AdaptHealth, LLC was founded in 2012 and is based in Phoenixville, Pennsylvania.

Cancer Treatment Company Profile

Cancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company's president provides management services. The company is based in Carson City, Nevada.

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with's FREE daily email newsletter.